You are currently viewing a new version of our website. To view the old version click .
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Article
  • Open Access

8 September 2006

Safety of Influenza Vaccination in Asthmatics

,
and
Klinika Pulmonologii i Alergologii Katedry Pneumonologii i Alergologii Uniwersytetu Medycznego w Łodzi, Łódź, Poland
*
Author to whom correspondence should be addressed.

Abstract

The common cause of exacerbations in asthmatics are viral infections. Infl uenza infection especially increases the risk of respiratory exacerbations. The ACIP report puts asthma among indications to regular infl uenza vaccinations. In practice, many physicians doubt in effectiveness and safety of vaccination in patients suffering from allergy. It caused such procedures were not included in asthma guidelines published by other authors. Our study confi rmed the safety of infl uenza split vaccine vaccination in asthmatics. We proved that vaccination had not any infl uence on asthma control in 14-day period after injection. We showed also high frequency of, mostly local, side effects. These events were generally mild and transient.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.